Log in

Relevant bibliographies by topics / 320503 Clinical Pharmacology and Therapeutics / Journal articles

To see the other types of publications on this topic, follow the link: 320503 Clinical Pharmacology and Therapeutics.

Journal articles on the topic '320503 Clinical Pharmacology and Therapeutics'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic '320503 Clinical Pharmacology and Therapeutics.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Horton, R. C., and M. J. Kendall. "Clinical pharmacology and therapeutics." Postgraduate Medical Journal 67, no. 794 (1991): 1042–54. http://dx.doi.org/10.1136/pgmj.67.794.1042.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Kendall, M. J., and R. C. Horton. "Clinical pharmacology and therapeutics." Postgraduate Medical Journal 66, no. 773 (1990): 166–85. http://dx.doi.org/10.1136/pgmj.66.773.166.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Fenn, G. C. "Clinical pharmacology and therapeutics." Postgraduate Medical Journal 66, no. 778 (1990): 686. http://dx.doi.org/10.1136/pgmj.66.778.686.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Mealey, Katrina L. "Clinical Pharmacology and Therapeutics." Veterinary Clinics of North America: Small Animal Practice 43, no. 5 (2013): xi—xiii. http://dx.doi.org/10.1016/j.cvsm.2013.05.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Someberg, John C. "Therapeutics, Clinical Phamacology, Molecular Pharmacology." American Journal of Therapeutics 1, no. 3 (1994): 171–72. http://dx.doi.org/10.1097/00045391-199410000-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Chung, Jae-Yong. "Digital therapeutics and clinical pharmacology." Translational and Clinical Pharmacology 27, no. 1 (2019): 6. http://dx.doi.org/10.12793/tcp.2019.27.1.6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Graaf, Piet H., and Kathleen M. Giacomini. "Clinical Pharmacology & Therapeutics 2030." Clinical Pharmacology & Therapeutics 107, no. 1 (2019): 13–16. http://dx.doi.org/10.1002/cpt.1705.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Rennie, J. M. "Neonatal Clinical Pharmacology and Therapeutics." Archives of Disease in Childhood 67, no. 10 (1992): 1323. http://dx.doi.org/10.1136/adc.67.10.1323-b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Hemilä, Harri. "Vitamin C in Clinical Therapeutics." Clinical Therapeutics 39, no. 10 (2017): 2110–12. http://dx.doi.org/10.1016/j.clinthera.2017.08.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Cheung, Bernard M. Y., and Henry K. C. Yau. "Clinical Therapeutics in Hong Kong." Clinical Therapeutics 41, no. 3 (2019): 592–97. http://dx.doi.org/10.1016/j.clinthera.2019.01.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Walson, Philip D. "Vaccines Update in Clinical Therapeutics." Clinical Therapeutics 35, no. 2 (2013): 105. http://dx.doi.org/10.1016/j.clinthera.2013.01.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Breckenridge, A. "Recent Advances: Clinical pharmacology and therapeutics." BMJ 310, no. 6976 (1995): 377–80. http://dx.doi.org/10.1136/bmj.310.6976.377.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Stein, C. "Clinical Pharmacology & Therapeutics—An update." Clinical Pharmacology & Therapeutics 73, no. 1 (2003): 1–3. http://dx.doi.org/10.1067/mcp.2003.31.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Turner, Paul. "Forum on Clinical Pharmacology and Therapeutics." Journal of the Royal Society of Medicine 82, no. 2 (1989): 117–18. http://dx.doi.org/10.1177/014107688908200226.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Jensen, R. L., D. Gilliespie, N. Ajewung, et al. "Pre-clinical Experimental Therapeutics and Pharmacology." Neuro-Oncology 12, Supplement 4 (2010): iv86—iv99. http://dx.doi.org/10.1093/neuonc/noq116.s13.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Waldman, S. A., N. B. Christensen, J. E. Moore, and A. Terzic. "Clinical pharmacology: the science of therapeutics." Clinical Pharmacology & Therapeutics 81, no. 1 (2007): 3–6. http://dx.doi.org/10.1038/sj.clpt.6100032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Waldman, S. A., N. B. Christensen, and A. Terzic. "Evolution of Clinical Pharmacology and Therapeutics." Clinical Pharmacology & Therapeutics 82, no. 3 (2007): 233–35. http://dx.doi.org/10.1038/sj.clpt.6100314.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Baber, Nigel. "Complementary medicines, clinical pharmacology and therapeutics." British Journal of Clinical Pharmacology 55, no. 3 (2003): 225. http://dx.doi.org/10.1046/j.1365-2125.2003.01814.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Peplinski, Lee S. "Ocular Therapeutics: Pharmacology and Clinical Application." Optometry and Vision Science 75, no. 8 (1998): 554. http://dx.doi.org/10.1097/00006324-199808000-00016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Reidenberg, Marcus M. "Clinical pharmacology and therapeutics: new directions?" Trends in Pharmacological Sciences 7 (January 1986): 381–82. http://dx.doi.org/10.1016/0165-6147(86)90392-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Graaf, Piet H. "Diversity in Clinical Pharmacology and Therapeutics." Clinical Pharmacology & Therapeutics 110, no. 4 (2021): 837–40. http://dx.doi.org/10.1002/cpt.2391.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Aaberg-Jessen, C., L. Fogh, B. Halle, et al. "EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY." Neuro-Oncology 15, suppl 3 (2013): iii37—iii61. http://dx.doi.org/10.1093/neuonc/not176.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Shader, Richard I. "Pharmacokinetics: The View From Clinical Therapeutics." Clinical Therapeutics 37, no. 2 (2015): 268–69. http://dx.doi.org/10.1016/j.clinthera.2015.01.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Reddy, Samba. "Clinical Pharmacology and Therapeutics of Antiepileptic Drugs." International Journal of Pharmaceutical Sciences and Nanotechnology 13, no. 6 (2020): 5165–80. http://dx.doi.org/10.37285/ijpsn.2020.13.6.1.

Full text

Abstract:

This article describes clinical antiepileptic drugs (AEDs) that are available for treatment of epilepsy. Epilepsy is characterized by repeated occurrence of seizures. Epileptic seizures are classified into focal onset (partial) and generalized onset (generalized) types. Around two-dozen AEDs are available for treating epilepsy. AEDs act on diverse molecular targets to selectively modify the abnormal excitability of neurons by reducing the focal seizure discharges or preventing spread of excitation. AEDs suppress seizures by blocking the voltage-gated sodium channels (phenytoin, carbamazepine,

APA, Harvard, Vancouver, ISO, and other styles

25

REIDENBERG, M. "Clinical pharmacology: The scientific basis of therapeutics." Clinical Pharmacology & Therapeutics 66, no. 1 (1999): 2–8. http://dx.doi.org/10.1016/s0009-9236(99)70047-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Stein, C. "Clinical pharmacology & therapeutics annual report 2002." Clinical Pharmacology & Therapeutics 74, no. 2 (2003): 99–101. http://dx.doi.org/10.1016/s0009-9236(03)00149-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Jodrell, Duncan. "Cancer therapeutics: medical oncology with clinical pharmacology." BMJ 332, no. 7536 (2006): s43.2—s45. http://dx.doi.org/10.1136/bmj.332.7536.s43-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Reidenberg, M. "Clinical Pharmacology & Therapeutics Annual report 2000." Clinical Pharmacology & Therapeutics 70, no. 3 (2001): 299–301. http://dx.doi.org/10.1067/mcp.2001.118185.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Mogg, Tony D. "Equine Cardiac Disease: Clinical Pharmacology and Therapeutics." Veterinary Clinics of North America: Equine Practice 15, no. 3 (1999): 523–34. http://dx.doi.org/10.1016/s0749-0739(17)30130-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Yang, F. H., B. Zhang, D. J. Zhou, et al. "LAB-EXPERIMENTAL (PRE-CLINICAL) THERAPEUTICS AND PHARMACOLOGY." Neuro-Oncology 14, suppl 6 (2012): vi25—vi37. http://dx.doi.org/10.1093/neuonc/nos222.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

De, Vries TP. "Presenting clinical pharmacology and therapeutics: general introduction." British Journal of Clinical Pharmacology 35, no. 6 (1993): 577–79. http://dx.doi.org/10.1111/j.1365-2125.1993.tb04184.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Reidenberg, Marcus M. "The history of CLINICAL PHARMACOLOGY & THERAPEUTICS." Clinical Pharmacology & Therapeutics 47 (February 1990): 277–79. http://dx.doi.org/10.1002/cpt.1990.47.s2.277.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Graaf, Piet H. "Clinical Pharmacology and Therapeutics: 2020 in Review." Clinical Pharmacology & Therapeutics 108, no. 6 (2020): 1117–19. http://dx.doi.org/10.1002/cpt.2061.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Mucklow, J. C. "Postgraduate education in clinical pharmacology and therapeutics." British Journal of Clinical Pharmacology 45, no. 4 (1998): 339–46. http://dx.doi.org/10.1046/j.1365-2125.1998.t01-1-00700.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Rawlins, Michael D. "Clinical pharmacology and therapeutics into the future." British Journal of Clinical Pharmacology 55, no. 5 (2003): 483–85. http://dx.doi.org/10.1046/j.1365-2125.2003.01840.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Dollery, C. T. "The future of clinical pharmacology and therapeutics." Clinical Pharmacology and Therapeutics 41, no. 1 (1987): 1–2. http://dx.doi.org/10.1038/clpt.1987.1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Reidenberg, Marcus M. "The history of Clinical Pharmacology & Therapeutics." Clinical Pharmacology and Therapeutics 47 (1990): 277–79. http://dx.doi.org/10.1038/clpt.1990.25.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Groll, Andreas H., Theodouli Stergiopoulou, Emmanuel Roilides, and Thomas J. Walsh. "Micafungin: pharmacology, experimental therapeutics and clinical applications." Expert Opinion on Investigational Drugs 14, no. 4 (2005): 489–509. http://dx.doi.org/10.1517/13543784.14.4.489.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

SIMONS, F. "H-receptor antagonists: Clinical pharmacology and therapeutics." Journal of Allergy and Clinical Immunology 84, no. 6 (1989): 845–61. http://dx.doi.org/10.1016/0091-6749(89)90377-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Orme, Michael. "European Association for Clinical Pharmacology and Therapeutics." European Journal of Clinical Pharmacology 57, no. 11 (2001): A827—A832. http://dx.doi.org/10.1007/s00228-001-0414-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

STEIN, C. "Clinical Pharmacology & Therapeutics Annual Report 2003." Clinical Pharmacology & Therapeutics 76, no. 3 (2004): 189–91. http://dx.doi.org/10.1016/j.clpt.2004.05.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

STEIN, C. "Clinical Pharmacology & Therapeutics annual report 2004." Clinical Pharmacology & Therapeutics 78, no. 2 (2005): 99–101. http://dx.doi.org/10.1016/j.clpt.2005.05.009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Wilson, AG, and GW Duff. "Translating immunobiology into clinical therapeutics." Current Opinion in Pharmacology 7, no. 4 (2007): 410–11. http://dx.doi.org/10.1016/j.coph.2007.07.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

WALDMAN, S. "The Molecular Therapeutics Section of the American Society for Clinical Pharmacology and Therapeutics." Clinical Pharmacology & Therapeutics 66, no. 4 (1999): 336–37. http://dx.doi.org/10.1053/cp.1999.v66.a100878.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Pirollo, Kathleen F., Antonina Rait, Leanne S. Sleer, and Esther H. Chang. "Antisense therapeutics: from theory to clinical practice." Pharmacology & Therapeutics 99, no. 1 (2003): 55–77. http://dx.doi.org/10.1016/s0163-7258(03)00053-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Chandra, Tanya, and Rohit Aggarwal. "Clinical trials and novel therapeutics in dermatomyositis." Expert Opinion on Emerging Drugs 25, no. 3 (2020): 213–28. http://dx.doi.org/10.1080/14728214.2020.1787985.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Alexander, Michael R., Jerry Taylor, and Carol L. Colvin. "Book Review: Clinical Pharmacy and Therapeutics." Drug Intelligence & Clinical Pharmacy 19, no. 5 (1985): 403. http://dx.doi.org/10.1177/106002808501900523.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

LEMMER, B. "THE CLINICAL RELEVANCE OF CHRONOPHARMACOLOGY IN THERAPEUTICS." Pharmacological Research 33, no. 2 (1996): 107–15. http://dx.doi.org/10.1006/phrs.1996.0016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Forloni, Gianluigi, Ignazio Roiter, and Fabrizio Tagliavini. "Clinical trials of prion disease therapeutics." Current Opinion in Pharmacology 44 (February 2019): 53–60. http://dx.doi.org/10.1016/j.coph.2019.04.019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

BRATER, D. CRAIG. "Medical Student Education in Clinical Pharmacology and Therapeutics." Annals of Internal Medicine 108, no. 1 (1988): 136. http://dx.doi.org/10.7326/0003-4819-108-1-136.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!